Evidence map›Paper›PMID 40227844›Full record

ArticleCancers2025

Effectiveness of First-Line Treatment with Anaplastic Lymphoma Kinase and ROS1 Protoncogene Inhibitors in Non-Small Cell Lung Cancer Patients-Real-World Evidence of Two Polish Cancer Centers.

Michał Gil, Kinga Winiarczyk, Paweł Krawczyk, Kamila Wojas-Krawczyk, Aleksandra Łomża-Łaba, Adrian Obara, Łukasz Gajek, Katarzyna Reszka, Andrzej Tysarowski, Jarosław Buczkowski and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Michał GilDepartment of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0002-9965-261X
Kinga WiniarczykDepartment of Lung Cancer and Chest Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology-National Research Institute, 02-781 Warsaw, Poland.
Paweł KrawczykDepartment of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.
Kamila Wojas-KrawczykDepartment of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0001-9947-5169
Aleksandra Łomża-ŁabaDepartment of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.
Adrian ObaraInstitute of Genetics and Immunology GENIM LCC, 20-609 Lublin, Poland.
Łukasz GajekInstitute of Genetics and Immunology GENIM LCC, 20-609 Lublin, Poland.
Katarzyna ReszkaInstitute of Genetics and Immunology GENIM LCC, 20-609 Lublin, Poland.
Andrzej TysarowskiDepartment of Genetic and Molecular Cancer Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology-National Research Institute, 02-781 Warsaw, Poland.
Jarosław BuczkowskiDepartment of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.
Izabela ChmielewskaDepartment of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.
Tomasz JankowskiDepartment of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.
Magdalena Szuba-GilMedical Diagnostic Laboratory, University Clinical Hospital No. 4, 20-954 Lublin, Poland.
Maciej StrzemskiDepartment of Analytical Chemistry, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0002-0039-4455
Dariusz M KowalskiDepartment of Lung Cancer and Chest Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology-National Research Institute, 02-781 Warsaw, Poland.ORCID 0000-0002-9452-3229
Janusz MilanowskiDepartment of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.
Maciej KrzakowskiDepartment of Lung Cancer and Chest Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology-National Research Institute, 02-781 Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ALK inhibitorsanaplastic lymphoma kinasenon-small cell-lung cancerrearrangement

Identifiers

PMID40227844
PMCPMC11988113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.